In addition, it was shown that the expression of the EIIIB+ fibronectin splice variant on neovasculature and a variety of tumor types is a target for CAR T cells that attack the stroma and vasculature of tumors and restrict tumor development. The gene discussed is FN1; the disease is neoplasm.